Bridger Management »

Catalyst Pharmaceutical Partners shares owned by Bridger Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Bridger Management from 13F filings

Historical chart of Bridger Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Bridger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Bridger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 185k 16.81

More positions owned by Bridger Management

Uber Technologies (UBER)
Godaddy Cl A (GDDY)
Caesars Entertainment (CZR)
Vertex Pharmaceuticals Incorporated (VRTX)
Morgan Stanley Com New (MS)
Eli Lilly & Co. (LLY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Bath &#38 Body Works In (BBWI)
Us Foods Hldg Corp call (USFD)
Endeavor Group Hldgs Cl A Com (EDR)
Charter Communications Inc N Cl A (CHTR)
Pfizer (PFE)
Docebo (DCBO)
Crown Holdings (CCK)
Xenon Pharmaceuticals (XENE)

View all positions for Bridger Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners